BRCA1 and breast carcinoma: Accordingly, a decrease in BRCA1 expression leads to a decreased proficiency in DNA repair, increased cisplatin sensitivity and improved survival in non-small cell lung cancer [43, 44], breast cancer [45], advanced esophageal squamous cell carcinoma [46] and ovarian cancer [47] patients.